Meurchin, France

Pierre Lebrun

This inventor holds 1 USPTO granted patent. Top assignee: Innobiochips. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Lebrun: Innovator in Hematology

Introduction

Pierre Lebrun is a notable inventor based in Meurchin, France. He has made significant contributions to the field of hematology through his innovative methods for detecting anti-erythrocyte antibodies. His work is particularly relevant in medical diagnostics, where accurate detection of antibodies can lead to better patient outcomes.

Latest Patents

Pierre Lebrun holds a patent for a method titled "Method for capturing and identifying cellular agglutinates for detecting multiplex anti-erythrocyte antibodies." This invention outlines an in-vitro method for detecting anti-erythrocyte antibodies in a sample. The method involves several steps, including bringing the sample into contact with test erythrocytes, creating a reaction mixture, and ascertaining the presence of hemagglutination reactions to detect antibodies. This innovative approach enhances the accuracy and efficiency of antibody detection.

Career Highlights

Throughout his career, Pierre has focused on developing methods that improve diagnostic processes in hematology. His dedication to research and innovation has led to advancements that benefit both medical professionals and patients. His work at Innobiochips has positioned him as a key player in the field of biomedical technology.

Collaborations

Pierre collaborates with various professionals in his field, including his coworker, Pauline Follet. Their combined expertise contributes to the development of cutting-edge technologies in medical diagnostics.

Conclusion

Pierre Lebrun's contributions to the field of hematology through his innovative patent demonstrate his commitment to improving medical diagnostics. His work continues to influence the way anti-erythrocyte antibodies are detected, ultimately benefiting patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…